MICHAEL JOHN TOMSICEK

Insider Reports History

Location
Bedford, MA
Signature
/s/ Adam D. Levy, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MICHAEL JOHN TOMSICEK:

Company Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Chief Financial Officer Common Shares 1,891 $118,193 $62.50 06 Aug 2021 Direct
CRISPR Therapeutics AG Chief Financial Officer Stock Option (Right to Buy) 131,000 11 Mar 2021 Direct
Milestone Pharmaceuticals Inc. Director Stock Option (right to buy) 40,000 10 Jun 2025 Direct
Acrivon Therapeutics, Inc. Director Stock Option (Right to Buy) 20,275 13 Jun 2025 Direct

Insider Reports Filed by MICHAEL JOHN TOMSICEK

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRV Acrivon Therapeutics, Inc. 13 Jun 2025 1 $0 4 Director 17 Jun 2025, 17:57
MIST Milestone Pharmaceuticals Inc. 10 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:19
MIST Milestone Pharmaceuticals Inc. 28 Aug 2024 1 $0 4 Director 29 Aug 2024, 16:15
ACRV Acrivon Therapeutics, Inc. 20 Jun 2024 1 $0 4 Director 24 Jun 2024, 17:28
MIST Milestone Pharmaceuticals Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:22
ACRV Acrivon Therapeutics, Inc. 14 Nov 2022 1 $0 4 Director 16 Nov 2022, 18:25
ACRV Acrivon Therapeutics, Inc. 09 Nov 2022 0 $0 3 Director 09 Nov 2022, 19:30
MIST Milestone Pharmaceuticals Inc. 19 Oct 2022 1 +$79,800 4 Director 21 Oct 2022, 19:01
MIST Milestone Pharmaceuticals Inc. 05 Jul 2022 1 $0 4 Director 11 Aug 2022, 18:03
CRSP CRISPR Therapeutics AG 06 Aug 2021 4 -$3,019,176 4 Chief Financial Officer 10 Aug 2021, 20:00
MIST Milestone Pharmaceuticals Inc. 14 Jun 2021 1 $0 4 Director 29 Jul 2021, 17:39